AQR Capital Management
AXDX icon

AQR Capital Management’s Accelerate Diagnostics AXDX Stock Holding History

AQR Capital Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,810
Closed -$28K – 2197
2022
Q2 		$28K Sell
2,810
-1,574
-36% -$13.9K ﹤0.01% 2152
2022
Q1 		$63K Buy
+4,384
New +$125K ﹤0.01% 2173
2018
Q1 		– Sell
-774
Closed -$203K – 2221
2017
Q4 		$203K Sell
774
-1,105
-59% -$259K ﹤0.01% 2150
2017
Q3 		$422K Sell
1,879
-807
-30% -$198K ﹤0.01% 1992
2017
Q2 		$734K Buy
2,686
+821
+44% +$223K ﹤0.01% 1769
2017
Q1 		$451K Buy
1,865
+282
+18% +$64.4K ﹤0.01% 1917
2016
Q4 		$329K Buy
+1,583
New +$376K ﹤0.01% 2038
2016
Q1 		– Sell
-1,331
Closed -$286K – 2213
2015
Q4 		$286K Sell
1,331
-716
-35% -$131K ﹤0.01% 2048
2015
Q3 		$331K Sell
2,047
-934
-31% -$202K ﹤0.01% 1889
2015
Q2 		$769K Sell
2,981
-1,223
-29% -$292K ﹤0.01% 1622
2015
Q1 		$946K Sell
4,204
-820
-16% -$171K ﹤0.01% 1441
2014
Q4 		$964K Sell
5,024
-670
-12% -$143K ﹤0.01% 1664
2014
Q3 		$1.22M Buy
5,694
+610
+12% +$119K ﹤0.01% 1520
2014
Q2 		$1.32M Buy
5,084
+1,530
+43% +$334K ﹤0.01% 1502
2014
Q1 		$775K Buy
3,554
+1,820
+105% +$270K ﹤0.01% 1815
2013
Q4 		$212K Buy
+1,734
New +$232K ﹤0.01% 2413

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return

AQR Capital Management's AXDX Position: Q3 2022 in Review

AQR Capital Management sold out of Accelerate Diagnostics (AXDX) in Q3 2022, closing a stake of 2,810 shares — an estimated $28K sold.

AQR Capital Management first reported a position in AXDX in Q4 2013 and held it in 16 quarters. The position peaked at $1.32M in Q2 2014. 84 funds tracked by Wall St. Rank hold AXDX as of Q3 2022.

  • AQR Capital Management reported no remaining Accelerate Diagnostics position as of Q3 2022 after selling out during the quarter.
  • AQR Capital Management sold 2,810 Accelerate Diagnostics shares in Q3 2022, an estimated $28K.
  • AQR Capital Management first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 16 quarters.
  • AQR Capital Management's Accelerate Diagnostics position peaked at $1.32M in Q2 2014.
  • 84 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.